Integrin subunit beta 3 mRNA (ITGB3 mRNA)

Integrin subunit beta 3 (ITGB3) mRNA is the messenger RNA transcript encoding the beta-3 subunit of the integrin family, which forms critical heterodimeric receptors such as alpha-IIb/beta-3 (GPIIb/IIIa) and alpha-v/beta-3. These receptors are vital for mediating cell-extracellular matrix adhesion, platelet aggregation, and signal transduction pathways involved in cell survival and proliferation (UniProt P05106). The therapeutic targeting of ITGB3 mRNA via siβ3 cargo involves the use of small interfering RNA (siRNA) to trigger the RNA interference (RNAi) pathway, resulting in the sequence-specific degradation of the transcript and subsequent knockdown of the beta-3 protein (PubMed: 25634305). This modality is particularly relevant in treating advanced cancers, where ITGB3 overexpression is linked to increased angiogenesis, epithelial-to-mesenchymal transition (EMT), and metastatic spread (PubMed: 30103514). Additionally, silencing ITGB3 mRNA is explored as a method to prevent thrombosis by inhibiting the formation of the alpha-IIb/beta-3 complex on platelets (NCBI Gene: 3690). Despite its potential, the primary safety concern is the risk of impaired hemostasis leading to bleeding, alongside the technical challenges of delivering siRNA cargo effectively to target tissues without inducing an immune response.

Other names

CD61 mRNAPlatelet glycoprotein IIIa mRNAGPIIIa mRNAITGB3 transcriptIntegrin beta-3 mRNA

RNA interference (RNAi) mediated degradation of ITGB3 mRNA, leading to reduced expression of Integrin beta-3 protein complexes.